Spyre Therapeutics, Inc. Common Stock

SYRE XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

Short interest (Apr 30)

14.2%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.40%

↑ 12.3%

Available Shares

700K

↓ 13.6%

Price Chart

Company Overview

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001636282

Asset Type: CS

Market Data

Market Cap: $6,005,941,057

Employees: 112

Status: Active

Short Interest

Current Borrow Fee 0.40%

Range: 0.40% - 0.40%

Available Shares 700K

Range: 400K - 650K

Recent Changes

Fee Change: ↓ 0.0%

Available Change: ↓ 12.9%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime